Search Results

• • 13 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Global health from a cancer care perspective

  Authors:Madeline Pesec and Tracy SherertzFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20158,525 words Report 1910LAuthor(s): Madeline Pesec aff1 , Tracy Sherertz [*] aff2 KEYWORDS cancer; chemotherapy; global health; low-income countries; middle-income countries; oncology; public health; radiotherapy; research; social...

• The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives

  Authors:Paraskevi Boura, Stylianos Loukides, Dimitra Grapsa, Apostolos Achimastos, and Konstantinos SyrigosFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20159,021 words Report 2710LAuthor(s): Paraskevi Boura aff1 , Stylianos Loukides aff1 , Dimitra Grapsa [*] aff1 , Apostolos Achimastos aff1 , Konstantinos Syrigos aff1 KEYWORDS adipokines; adiponectin; adipose tissue; cancer cachexia;...

• Biomarkers to detect Wilms tumors in pediatric patients: where are we now?

  Authors:Jocelyn Charlton, Vesna Pavasovic, and Kathy Pritchard-JonesFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20158,772 words Report 1960LAuthor(s): Jocelyn Charlton aff1 , Vesna Pavasovic aff1 , Kathy Pritchard-Jones [*] aff1 KEYWORDS biomarker; cancer; heterogeneity; liquid biopsy; prognosis; Wilms tumor Wilms tumor overview Wilms tumor (WT)...

• Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma

  Author:A Keith StewartFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 201511,557 words Report 2160LAuthor(s): A Keith Stewart [*] aff1 KEYWORDS carfilzomib; efficacy; multiple myeloma; proteasome inhibitor; relapsed and/or refractory; safety Multiple myeloma (MM), a plasma cell dyscrasia, is the second most...

• Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lung

  Authors:Peter E Hall, James Spicer, and Sanjay PopatFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 201513,700 words Report 1950LAuthor(s): Peter E Hall aff1 , James Spicer [*] aff1 aff2 , Sanjay Popat aff3 KEYWORDS afatinib; immune checkpoint; lung cancer; nivolumab; oncogenic drivers; pan-ErbB inhibitors; squamous cell carcinoma; targeted...

• Next revolution in molecular theranostics: personalized medicine for urologic cancers

  Authors:Fouad Aoun, Hampig Raphael Kourie, Carlos Artigas, and Thierry RoumeguereFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 201512,159 words Report 1900LAuthor(s): Fouad Aoun [*] aff1 aff2 , Hampig Raphael Kourie aff1 aff2 , Carlos Artigas aff1 aff2 , Thierry Roumeguère aff1 KEYWORDS bombesin; carbonic anhydrase; kidney cancer; neurotensin; prostate cancer; PSMA;...

• Functional genetic variants in pre-miR-146a and 196a2 genes are associated with risk of lung cancer in North Indians

  Authors:Kushaldeep Kaur Sodhi, Charu Bahl, Navneet Singh, Digamber Behera, and Siddharth SharmaFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20159,629 words Report 1610LAuthor(s): Kushaldeep Kaur Sodhi aff1 , Charu Bahl aff1 , Navneet Singh aff2 , Digamber Behera aff2 , Siddharth Sharma [*] aff1 KEYWORDS genotype; lung cancer; miR-146a ; miR-196a2 ; single nucleotide polymorphism...

• Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma

  Authors:Wafa'a A Al-Jizani, Mubarak M Al-Mansour, Turki M Al-Fayea, Ruaa U Shafi, Ghieth A Kazkaz, Ali M Bayer, et al.From:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20155,009 words Report 1500LAuthor(s): Wafa'a A Al-Jizani aff1 , Mubarak M Al-Mansour aff1 , Turki M Al-Fayea aff1 , Ruaa U Shafi aff1 , Ghieth A Kazkaz aff2 , Ali M Bayer aff2 , Meteb E Al-Foheidi aff1 , Ezzeldin M Ibrahim [*] aff2 KEYWORDS...

• Development of PROSTVAC immunotherapy in prostate cancer

  Authors:Parminder Singh, Sumanta K Pal, Anitha Alex, and Neeraj AgarwalFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20157,568 words Report 1650LAuthor(s): Parminder Singh aff1 , Sumanta K Pal aff2 , Anitha Alex aff3 , Neeraj Agarwal [*] aff3 KEYWORDS pox virus immunotherapy; prostate cancer; PROSTVAC Prostate cancer is the second leading cause of...

• How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer

  Authors:Stephane Renaud and Pierre-Emmanuel FalcozFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20152,150 words Report 1820LAuthor(s): Stéphane Renaud aff1 aff2 , Pierre-Emmanuel Falcoz [*] aff1 KEYWORDS BRAF; colorectal cancer; epithelial-to-mesenchymal transition; HIF; KRAS; lung metastasectomy; miRNA Even though still subject of...

• Hypofractionated radiation therapy versus conventionally fractionated radiation therapy for early-stage breast cancer: how do we choose?

  Authors:Suzanne B Evans and James B YuFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20151,905 words Report 1700LAuthor(s): Suzanne B Evans aff1 aff2 , James B Yu [*] aff1 aff2 KEYWORDS breast cancer; breast conserving therapy; hypofractionated whole-breast radiotherapy; hypofractionation; radiotherapy Hypofractionated...

• Targeting aggressive cancers with an artificial sweetener: could saccharin be a lead compound in anticancer therapy?

  Authors:Brian P Mahon, Cynthia O Okoh, and Robert McKennaFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20152,370 words Report 2550LAuthor(s): Brian P Mahon aff1 , Cynthia O Okoh aff1 , Robert McKenna [*] aff1 KEYWORDS anticancer therapies; carbonic anhydrase IX and XII; saccharin; tumor hypoxia Since its serendipitous 'sweet' discovery in...

• How can we decrease suicide risk in cases of genitourinary cancer?

  Authors:Zachary Klaassen, Grace Yaguchi, and Martha K TerrisFrom:Future Oncology (Vol. 11, Issue 15) Peer-Reviewed

  Aug. 20151,958 words Editorial 1820LAuthor(s): Zachary Klaassen [*] aff1 , Grace Yaguchi aff1 , Martha K Terris aff1 KEYWORDS bladder cancer; prostate cancer; SEER; suicide In 2013, more than 41,000 people committed suicide in the USA,...